Cutaneous and Systemic Leishmaniasis Drugs Market Key Drivers and Forecast 2025-2032
Cutaneous and Systemic Leishmaniasis Drugs Market Trends And Drivers The Cutaneous and Systemic Leishmaniasis Drugs Market was valued at USD 850 million in 2022 and is projected to reach USD 1.5 billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030. The increasing prevalence of leishmaniasis in endemic regions, particularly in parts […]
Continue Reading